[1. Kuriloff DB, Sanborn KV. Rapid intraoperative localization of parathyroid glands using methylene blue infusion. Otolaryngology- Head Neck Surgery. 2004;131:616-22.10.1016/j.otohns.2004.04.02615523436]Search in Google Scholar
[2. Patel HP, Chadwick DR, Harrison BJ, Balasubramanian SP. Systematic review of intravenous methylene blue in parathyroid surgery. Br J Surg. 2012;99:1345-52.10.1002/bjs.881422961511]Search in Google Scholar
[3. Ramsay RR, Dunford C, Gilman PK. Methylene blue and serotonin toxicity: inhibition of monoamine oxidase A (MAO A) confirms a theoretical prediction. Br J Pharmacol. 2007;152:946-51.10.1038/sj.bjp.0707430207822517721552]Search in Google Scholar
[4. Dunkley EJ, Isbister GK, Sibbritt D, et al. The Hunter Serotonin Toxicity Criteria: simple and accurate diagnostic rules for serotonin toxicity. QJM. 2003;96:635.10.1093/qjmed/hcg10912925718]Search in Google Scholar
[5. Mowry JB, Spyker DA, Cantilena LR Jr, Bailey JE, Ford M. 2012 Annual Report of the American Association of Poison Control Centers’ National Poison Data System (NPDS): 30th Annual Report. ClinToxicol (Phila). 2013;51:949-1229.10.3109/15563650.2013.86390624359283]Search in Google Scholar
[6. Shopes E, Wayne Gerard W, Baughman J. Methylene blue encephalopathy: a case report and review of published cases. AANA Journal. 2013;81:215-21.]Search in Google Scholar
[7. Khan MAS, North AP, Chadwick DR. Prolonged Postoperative Altered Mental Status After Methylene Blue Infusion During Parathyroidectomy: A Case Report and Review of the Literature. Ann R Coll Surg Engl. 2007;89:W9-W11.10.1308/147870807X160434196458617346391]Search in Google Scholar
[8. Johnson N, Soar J, Robinson S. Concurrent administration of methylene blue and a selective serotonin reuptake inhibitor: a recipe for serotonin syndrome. Journal of the Intensive Care Society. 2012;13:256-8.10.1177/175114371201300318]Search in Google Scholar
[9. Khavandi A, Whitaker J, Gonna H. Serotonin toxicity precipitated by concomitant use of citalopram and methylene blue. Med J Aust. 2008;189:534-5.10.5694/j.1326-5377.2008.tb02168.x18976207]Search in Google Scholar
[10. Ng BKW, Cameron AJD. Serotonin syndrome following methylene blue infusion during parathyroidectomy: a case report and literature review. Can J Anaesthesiol. 2008;55:1-5.]Search in Google Scholar
[11. Martindale SJ, Stedeford JC. Neurological sequelae following methylene blue injection for parathyroidectomy. Anaesthesia. 2003;58:1041-2.10.1046/j.1365-2044.2003.03415_23.x12969068]Search in Google Scholar
[12. Isbister GK, Buckley NA, Whyte IM. Serotonin toxicity: a practical approach to diagnosis and treatment . Med J Aust. 2007;187:361-5.10.5694/j.1326-5377.2007.tb01282.x17874986]Search in Google Scholar
[13. MHRA Drug Safety Update. 2009, vol 2 issue 9:3.]Search in Google Scholar
[14. Methylene blue: Drug Safety Communication - Serious CNS Reactions possible when given to patients taking certain psychiatric medication. July 2011 (updated October 2011)]Search in Google Scholar
[15. Lead Directorate: Marketed Health Product Directorate. Methylene blue injectable in combination with serotonin reuptake inhibitors - Association with serotonin toxicity - Notice to Hospitals. 2011. Available at: http://healthycanadians.gc.ca/recall-alert-rappel-avis/hc-sc/2011/14648a-eng.php]Search in Google Scholar
[16. Hall M, Buckley N. Serotonin syndrome. Australian Prescriber. 2003;26:62-3.10.18773/austprescr.2003.044]Search in Google Scholar